Panacea Biotec has settled a patent infringement case with Sanofi Healthcare India over a hexavalent vaccine. Sanofi will not ...

Panacea Biotec has reached a settlement with Sanofi Healthcare India concerning a patent infringement for its fully liquid ...

Panacea Biotec initially filed the lawsuit in May 2021, seeking to stop Sanofi from marketing its Shan6 vaccine, which it ...

The U.S. Government's development finance institution, the U.S. International Development Finance Corporation (DFC), has ...

In May 2021, Panacea Biotec instituted a suit before the Delhi High Court seeking to restrain Sanofi Healthcare India Pvt Ltd ...

Panacea Biotec and Sanofi Healthcare India have reached a settlement agreement over a patent infringement lawsuit concerning ...

Panacea Biotec has resolved a patent infringement lawsuit with Sanofi Healthcare concerning its EasySix hexavalent vaccine.

Panacea Biotec reaches settlement with Sanofi over hexavalent vaccine patent, shares hit new high, expanding manufacturing capacity.

Panacea has agreed to forego its claim for damages & rendition of accounts in the proceedings against Sanofi as prayed in the ...

Panacea Biotec has settled a patent dispute with Sanofi Healthcare India, leading to a rise in its stock. The Delhi High ...